To include your compound in the COVID-19 Resource Center, submit it here.

PTAB sovereign immunity likely to move to federal courts

The Patent Trial and Appeal Board has rejected an attempt by Allergan plc (NYSE:AGN) to shield patents on Restasis cyclosporine from an inter

Read the full 238 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE